- $369.54m
- $469.59m
- $130.19m
- 18
- 34
- 12
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 51.2 | 48.9 | 72.5 | 88.6 | 130 |
Cost of Revenue | |||||
Gross Profit | 34.4 | 34.4 | 54.3 | 63.2 | 90.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 56 | 48.6 | 69.5 | 86.7 | 135 |
Operating Profit | -4.8 | 0.312 | 2.98 | 1.92 | -5.03 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.125 | -3.42 | -17.9 | -14 | -23.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.125 | -3.42 | -18 | -14.1 | -24.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.168 | -3.36 | -18 | -14.1 | -24.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.168 | -3.36 | -18.5 | -14.1 | -24.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.159 | -0.119 | -0.718 | -0.637 | -0.625 |